Akira Mima
Impact in
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
- Diabetes Management and Research
Papers in
- Nephrology 38
- Chronic Kidney Disease and Diabetes 23
- Renal Diseases and Glomerulopathies 14
- Dialysis and Renal Disease Management 7
-
- Diabetes Treatment and Management 17
- Diabetes Management and Research 4
- Co-authors
- George L. KingChristian Rask‐MadsenKoji MizutaniShigeru UeshimaMunehiro KitadaMotonobu MatsumotoChenzhong LiPedro Geraldes
- Journals
- PLoS ONE (4 papers)Scientific Reports (3 papers)Diabetes (3 papers)Advances in Therapy (3 papers)Clinical Nephrology (2 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Akira Mima
65 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 91
- Nephrology 524
- Endocrinology, Diabetes and Metabolism 641
- Clinical Biochemistry 147
- Molecular Biology 542
- Biochemistry 52
Countries citing papers authored by Akira Mima
This map shows the geographic impact of Akira Mima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Mima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Mima more than expected).
Fields of papers citing papers by Akira Mima
This network shows the impact of papers produced by Akira Mima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Mima. The network helps show where Akira Mima may publish in the future.
Co-authors
The 25 scholars most cited alongside Akira Mima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 29 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 42 | |
| 14 | 2017 | 4 | |
| 15 | 2016 | 37 | |
| 16 | 2012 | 179 | |
| 17 | 2011 | 46 | |
| 18 | 2009 | 3 | |
| 19 | 2008 | 1 | |
| 20 | 2006 | 64 |
About Akira Mima
Akira Mima is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Hepatology and Transplantation, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (23 papers), Diabetes Treatment and Management (17 papers), Renal Diseases and Glomerulopathies (14 papers), Dialysis and Renal Disease Management (7 papers), TGF-β signaling in diseases (7 papers), Pancreatic function and diabetes (7 papers), Metabolism and Genetic Disorders (4 papers) and Diabetes Management and Research (4 papers). The work is most often cited by research in Nephrology (524 citations), Endocrinology, Diabetes and Metabolism (641 citations), Clinical Biochemistry (147 citations), Molecular Biology (542 citations) and Biochemistry (52 citations). Akira Mima has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include George L. King, Christian Rask‐Madsen, Koji Mizutani, Shigeru Ueshima, Munehiro Kitada, Motonobu Matsumoto, Chenzhong Li, Pedro Geraldes, Toshio Doi and Takeshi Matsubara. Their work appears in journals such as PLoS ONE, Scientific Reports, Diabetes, Advances in Therapy and Clinical Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.